Technology | January 12, 2012

Hyperthermia System Increases Cervical Cancer Response to Radiation Therapy

 

January 12, 2012 -- The U.S. Food and Drug Administration (FDA) recently cleared a hyperthermia system designed to warm cervical cancer tumors so they respond better to radiation therapy treatments.

The BSD Medical BSD-2000 Hyperthermia System delivers focused therapeutic heating (hyperthermia) with temperatures greater than 104 degrees Fahrenheit, to cancerous tumors by applying radiofrequency (RF) energy. The energy is delivered in the frequency range of 75 to 120 MHz. The BSD-2000 delivers RF energy to a patient using a power source and an array of antennae that surround the patient’s body. The energy can be electronically focused to produce a localized electromagnetic power field. This can be adjusted to target the three-dimensional shape, size and location of the tumor, providing dynamic control of the heat delivered to the tumor region. This method of therapeutic heating utilizes the adjustment of frequency, phase, and amplitude from multiple power sources, along with an applicator selection and patient positioning, to optimize heating of the targeted body tissues.

The system is indicated for use in conjunction with radiation therapy for the treatment of cervical cancer patients who are ineligible for chemotherapy. The FDA said it increases the response of tumor cells to radiation therapy.

The FDA said the system should not be used in patients who have:

  • medical devices that are implanted, carried or worn on their bodies
  • severe dysfunction of the heart or lungs
  • electrically conductive, metal, or foreign objects in, on or attached to their body
  • severe high or low blood pressure
  • severe cerebrovascular disease, or
  • when the treating physician cannot place either a temperature sensor into the tumor or into a body cavity.

For a summary of safety and probable benefit (SSPB) and product labeling, visit www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=h090002

 

 

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init